Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Mithra Pharmaceuticals S.A.
  6. Summary
    MITRA   BE0974283153

MITHRA PHARMACEUTICALS S.A.

(MITRA)
  Report
Real-time Euronext Bruxelles  -  11:35 2022-12-02 am EST
4.400 EUR   -0.11%
11/28Mithra maintains its operational calendar
AQ
11/01Mithra has access to the second tranche of the Highbridge/Whitebox loan facility
AQ
10/24Mithra and Fuji announce approval of NEXTSTELLIS in Thailand
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
11/28/2022 11/29/2022 11/30/2022 12/01/2022 12/02/2022 Date
4.57(c) 4.415(c) 4.515(c) 4.405(c) 4.4(c) Last
387 454 313 654 443 911 186 007 194 903 Volume
+6.03% -3.39% +2.27% -2.44% -0.11% Change
More quotes
Estimated financial data (e)
Sales 2022 150 M 157 M 157 M
Net income 2022 64,7 M 67,8 M 67,8 M
Net Debt 2022 227 M 238 M 238 M
P/E ratio 2022 3,32x
Yield 2022 -
Sales 2023 128 M 134 M 134 M
Net income 2023 -33,4 M -35,0 M -35,0 M
Net Debt 2023 219 M 230 M 230 M
P/E ratio 2023 -6,70x
Yield 2023 -
Capitalization 237 M 249 M 249 M
EV / Sales 2022 3,10x
EV / Sales 2023 3,57x
Nbr of Employees 300
Free-Float 66,8%
More Financials
Company
Mithra Pharmaceuticals S.A. is a Belgian biotech company dedicated to transforming Women's Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra's goal is to develop products offering better efficacy, safety and convenience, meeting women's needs throughout their life span. Mithra Pharmaceuticals S.A. explores the potential of the unique native estrogen... 
Sector
Pharmaceuticals
Calendar
03/03Earnings Release
More about the company
Ratings of Mithra Pharmaceuticals S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about MITHRA PHARMACEUTICALS S.A.
11/28Mithra maintains its operational calendar
AQ
11/01Mithra has access to the second tranche of the Highbridge/Whitebox loan facility
AQ
10/24Mithra and Fuji announce approval of NEXTSTELLIS in Thailand
AQ
10/18Mithra - Presentation of Donesta Phase 3 Topline Efficacy Results at the NAMS World Con..
AQ
10/12Mithra Pharmaceuticals S A : announces positive preclinical data demonstrating Estetrol's ..
PU
10/05Mithra releases invitation to its extraordinary securities holders meeting
AQ
10/04Mithra Pharmaceuticals S A : releases invitation to its extraordinary securities holders' ..
PU
10/04MITHRA PHARMACEUTICALS S.A. : Extraordinary general sharehol..
CO
09/27Mithra Pharmaceuticals S A : Conversion of a portion of the loans from Highbridge and Whit..
PU
09/27Mithra Pharmaceuticals S A : 2022 Half Year Results
PU
09/23Mithra Pharmaceuticals SA Reports Earnings Results for the Half Year Ended June 30, 202..
CI
09/23Transcript : Mithra Pharmaceuticals SA, H1 2022 Earnings Call, Sep 23, 2022
CI
09/23Mithra Pharmaceuticals S A : Half Year 2022 Results
PU
09/23Mithra Pharmaceuticals S A : Announces 2022 Half Year Results
PU
09/23MITHRA PHARMACEUTICALS S.A. : 1st-half-year results
CO
More news
News in other languages on MITHRA PHARMACEUTICALS S.A.
11/27Uitgelicht: laagste koers ooit voor Mithra
10/31Mithra ontvangt tweede tranche van Highbride en Whitebox
10/24Groen licht voor anticonceptiepil Mithra in Thailand
10/13Bolsa de Madrid: El precio es el que usted cree que es
10/13Tel est prix qui croyait prendre
More news
ETFs positioned on MITHRA PHARMACEUTICALS S.A.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Lyxor MSCI EMU Small Cap (DR) - Dist - EUR0.05%0.04%Europe
UBS ETF - MSCI EMU Small Cap A-dis - EUR0.04%-0.39%Europe
IShares MSCI EAFE Small-Cap ETF - USD0.01%1.75%EAFE
IShares MSCI Europe Small-Cap ETF - USD0.01%1.80%Europe
IShares Core MSCI All Country World ex Cana...0%3.38%-World
More ETFs positioned on MITHRA PHARMACEUTICALS S.A.
Chart MITHRA PHARMACEUTICALS S.A.
Duration : Period :
Mithra Pharmaceuticals S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MITHRA PHARMACEUTICALS S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 4,40 €
Average target price 22,50 €
Spread / Average Target 411%
EPS Revisions
Managers and Directors
Leon van Rompay Chief Executive Officer
Christophe MarÚchal Chief Financial Officer
Christian Moretti Chairman
Graham K. Dixon CSO, Head-Research & Development
Koen Hoffman Independent Director
Sector and Competitors